Press release

FIS APPROVES FINANCIAL STATEMENTS FOR 2024 THE LEADING GROUP IN THE PRODUCTION OF APIs FOR THE PHARMACEUTICAL INDUSTRY REPORTS GROWTH IN KEY ECONOMIC AND FINANCIAL RATIOS REVENUES AT €812 MILLION, UP 9% COMPARED TO THE PREVIOUS YEAR; EBITDA MARGIN ADJUSTED IMPROVED TO 19% OF REVENUES AND REPORTED EBITDA UP BY 56% FURTHER DEVELOPMENT OF ALL […]